< Back to all clusters
[HEALTH] · Brazil · 64 sources

started · updated

Anvisa approves Brazil's first generic semaglutide medication

Anvisa, Brazil's National Health Surveillance Agency, has approved the country's first generic semaglutide medication. The registration was granted to the pharmaceutical company EMS, which will market the synthetic version. Under Brazilian law, generic drugs must be priced at least 35% lower than their reference products.

In addition to the generic version, Anvisa also authorized a similar semaglutide medication from Germed, which will be sold under the brand name Semaclique. Both products are indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus, to be used in conjunction with diet and exercise.

The approved semaglutide presentations include various injectable pen and kit options with a concentration of 1.34 mg/mL. These medications require a medical prescription in two copies and must be stored in refrigerators at temperatures between 2 °C and 8 °C.

Entities

Anvisa · Brazil · EMS · Germed · Ozivy · Semaclique · semaglutide

Claims

What the coverage asserts, and how many sources carry each claim.

Sources